NCT03235154 - A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

September 26, 2019

Study Completion Date

September 26, 2019

Conditions

Hepatitis C, ChronicHepatitis COpiate Dependence

Interventions

DRUG

sofosbuvir/velpatasvir

12 week treatment with once daily sofosbuvir/velpatasvir fixed dose combination therapy. Tablets are formulated with 400mg sofosbuvir and 100mg velpatasvir in pink, diamond-shaped, film coated tablets.

Trial Locations (1)

02143

Cambridge Health Alliance Outpatient Addiction Services, Somerville